in the newly formed tissue. Such a strategy may be useful for applications in bone tissue engineering, for example to enhance revascularization and ossification in non-healing fractures. In this context, a recent study has shown a direct correlation between angiogenesis and bone repair in various models of bone damage [11] .
We have previously described a three-dimensional spheroidal coculture model of human primary endothelial cells and human primary osteoblasts (hOBs), which was designed to improve angiogenesis in bone tissue engineering [12] . In 
Materials and methods

Cell culture
Human osteoblasts (hOBs) were isolated from femoral heads with the informed consent of the patients according to hospital ethic committee guidelines. Isolation of hOBs from bone material was performed as previously described [12] . Osteoblasts 
Generation of endothelial spheroids
HUVEC spheroids (1000 cells/spheroid) were generated as previously described [13] . Cells 
Implantation of PBCB scaffolds onto the surface of the chick embryo chorioallantoic membrane
The CAM assay was performed as previously described [14] . (Fig. 3A) . Double staining with antibodies against human vimentin and human CD31 revealed a homogeneous distribution of human osteoblasts within the human blood vessel network (Fig. 3B) (Fig. 4) .
Similarly, when HUVEC-spheroid/hOB-seeded scaffolds were implanted subcutaneously into immunodeficient SCID mice and harvested after 21 days, the formation of a dense human neovasculature could be observed as demonstrated by hCD34/vimentin double-staining (Fig. 5A) (Fig. 4) (Fig. 5A, B) . Implantation of plain human osteoblasts also revealed a homogeneous distribution of viable cells, but without any sign of neovascularization (Fig. 5D ). As expected, implants seeded with human osteoblasts alone failed to form any detectable hCD34 + microvessels (data not shown). (Fig. 5E) . [15] [16] [17] , gene therapeutic approaches [18, 19] or cell-based therapies using endothelial cells [9, 10] . [13, 20] [21] . Because it has been recently demonstrated that endothelial cell spheroids are able to develop lumenized capillary sprouts in vivo [22] , we intended to investigate whether this system is also suitable for the in vivo formation of stable blood vessels in bone tissue engineering applications in combination with an osteoconductive PBCB scaffold. [11, 23] . Therefore, we have used endothelial cell spheroids in combination with hOBs to investigate whether such a blood vessel network can be generated in vivo in a three-dimensional osteoblast environment. Fibrin gelimmobilized HUVEC spheroids and hOBs were co-seeded in PBCB scaffolds and assessed for their angiogenic potential in the CAM assay as well as in a subcutaneous SCID mouse model. In both assays, the development of a complex three-dimensional network of perfused human neovessels could be detected.
Double-staining for human CD34 and smooth muscle ␣-actin on cross-sections of implants seeded with HUVEC-spheroids and hOBs showed that the newly formed blood vessels were covered with smooth muscle ␣-actin-positive mural cells, suggesting that the vessels were stabilized by murine pericytes or smooth muscle cells recruited from the surrounding mouse tissue
In summary, we have shown that endothelial cells grown in three-dimensional spheroid culture and co-implanted with hOBs into PBCB-scaffolds, organize in vivo into tubes and form dense functional vessel networks.
Discussion
Construction of stable blood vessels still represents a great challenge in tissue engineering applications. Without the generation of a functional vascular network, implanted cells will undergo apoptosis due to limitations in oxygen and nutrient supply. Multifarious strategies to induce therapeutic angiogenesis are described and comprise the use of various recombinant angiogenic growth factors such as VEGF and bFGF
In this study, we have employed a three-dimensional endothelial cell spheroid system to improve in vivo vascularization in bone tissue constructs. The spheroidal endothelial cell culture model was originally developed as an in vitro angiogenesis assay for studying endothelial cell differentiation and maturation
. In addition, this system proved to be suitable as an in vitro assay for the identification of pro-or anti-angiogenic molecules
Fig. 2 Cell-seeded PBCB scaffold prior to implantation. (A) Phasecontrast microscopy of a single HUVEC spheroid surrounded by co-seeded human osteoblasts. Cells were fibrin gel-immobilized and seeded into the PBCB scaffold (scale bar, 100 µm). (B) hCD31/vimentin double staining of paraffin section of a HUVEC spheroid (brown) surrounded by human osteoblasts (red) 24 hrs after cell seeding (scale bar, 50 µm). (C) hCD31/vimentin double staining of paraffin section after 3 days of in vitro growth showing a large hCD31 + lumenal structure (scale bar, 100 µm). (D) hCD31/vimentin double staining of paraffin section after 14 days of growth in vitro (scale bar, 100 µm).
Fig. 3 Cell-seeded PBCB scaffolds incubated on top of the chick embryo chorioallantoic membrane for 8 days. (A) hCD31/vimentin double staining of paraffin section of a scaffold seeded with HUVEC spheroids and human osteoblasts at low magnification (scale bar, 200 µm). (B) hCD31/vimentin double staining of cross-section at higher magnification showing human blood vessels (brown) and human osteoblasts (red) dispersed between the blood vessels (scale bar, 50 µm). (C) hCD31 staining of perfused human blood vessels (brown) containing intralumenal haematoxylin-stained avian erythrocytes (pale blue) (scale bar, 50 µm).
It is well known that tissue engineering of bone substitutes is strongly dependent on vascularization, because no ossification takes place in the absence of blood supply
In the context of the SCID mouse model, we have also seen that the newly formed human vasculature was covered by smooth muscle ␣-actin-positive mural cells, indicating that the neovessels were stabilized by murine perivascular cells recruited from the surrounding mouse tissue.
Schechner et al. [9] [10] . Similarly, Levenberg and colleagues [27] [29] , is biocompatible [30] , osteoconductive [31] 
